AzTrials
AzTrials

Healthy Young AdultsBIPBIPNCT07859917

Study in Young Adults to Understand How Glasses With a Small Reading Addition Affect Focusing and Eye Coordination During Vision Tasks

A study testing Eye exam, Questionnaires and Washout lenses in people with Healthy Young Adults and Accommodation Disorder, run by Essilor International at 1 site in United Kingdom.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This clinical study aims to understand how glasses with a small reading addition affect the way the eyes focus and work together in young adults with normal near vision. Some people experience focusing difficulties or visual discomfort during near-vision activities such as reading or using digital devices. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Young Adults, Accommodation Disorder
What is being tested?
Eye exam, Questionnaires and Washout lenses
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
1 siteUnited Kingdom
Study dates
Sep 2026to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 1.Voluntary person, fluent in English willing to follow the protocol, able to read and understand the information form and give his free and informed consent
  • 2.Aged between 18 and 35 years old
  • 3.Non-presbyopic
  • 4.Wears glasses for at least 6 hours per day
  • 5.Distance refractive error (Sphere) within the range of [-6.00D to +3.00D] (with cylinder in the negative form)
  • 6.Cylindrical component of the refractive error within the range of [0 to -2 D] in both eyes
Show all 11Show fewer
  • 7.Anisometropia within the range of [0.00D to +1.50D]
  • 8.A visual acuity with new prescription at distance and at near greater or equal to 20/25 (6/7.5, 0.1 logMAR) monocularly and binocularly
  • 9.No visual acuity difference inferior or equal to 0.1 logMAR between right and left eye at distance and at near
  • 10.Phakic eyes
  • 11.Daily activities of the participant mostly in near vision (at least 6 hours during weekday)

Who cannot join

  • 1.Pregnant woman or nursing
  • 2.Persons deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent and persons admitted to a health or social institution for purposes other than research
  • 3.Adults who are unwilling or unable to express consent
  • 4.Participant in exclusion period from another study
  • 5.Persons wearing or that have previously worn any type of anti-fatigue or lenses with a boost
  • 6.Persons who don't wear glasses
Show all 15Show fewer
  • 7.Severe ocular pathology declared, involving a loss of visual field as in glaucoma or involving a loss of acuity and strong discomfort in environments with little or too much light as in retinitis pigmentosa or moderate or severe dry eye diagnosed.
  • 8.Reported neurological deficit, including a history of epilepsy or sensorimotor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders, dizziness)
  • 9.Overt aphakic or pseudophakic (intraocular implant)
  • 10.Constant or intermittent diplopia or double vision with a +1.00D lens at near
  • 11.Ocular diseases nor general pathologies with an impact on visual field or vision.
  • 12.Reported systemic condition, medical treatment or medication that affects vision
  • 13.Manifest or decompensating latent strabismus, amblyopia, nystagmus.
  • 14.Known contraindication to cyclopentolate 1% or its excipients
  • 15.Known risk of angle-closure glaucoma.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom1 site
  • City St Georges's, University of London

    London

    Miriam Conway, PhD, +44 20 7040 8392, miriam.conway.1@city.ac.uk

Other trials in United Kingdom

About this study

Official title: Impact of a Small Power Addition Lens on the Accommodative and Binocular Profiles

This clinical study aims to understand how glasses with a small reading addition affect the way the eyes focus and work together in young adults with normal near vision.

Some people experience focusing difficulties or visual discomfort during near-vision activities such as reading or using digital devices. This study will evaluate whether glasses with a small reading addition can help reduce these difficulties and improve visual comfort.

Read more

Researchers will compare two different pairs of glasses designed to provide additional support for near vision. They will assess how each pair affects eye focusing and eye coordination using standard optometric examinations.

Participants will:

  • Wear three pairs of glasses, each for approximately 4 weeks.
  • Complete eye examinations to evaluate focusing ability and eye coordination.
  • Answer questionnaires about visual comfort, eye strain, and overall quality of vision.
Being tested
Eye exam, Questionnaires, Washout lenses, Reference lenses, Test lenses

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eye examDevice

    An optometric eye exam

  • QuestionnairesOther

    Questionnaires on the eye fatigue and the quality of vision

  • Washout lensesDevice

    Also called Single Vision Stylis Cz Sapph

    Standard single-vision spectacle lenses prescribed according to each participant's refractive error and worn during the washout period before allocation to the study lenses.

  • Reference lensesDevice

    Spectacles lenses optimized near vision lenses for the comparator

  • Test lensesDevice

    Spectacles lenses optimized near vision lenses for the test

Study groups in NCT07859917
Study groupRoleWhat they receive
1st worn pair of glasses : Reference / 2nd worn pair of glasses : TestExperimentalThe very first pair of lenses worn before the experimental arm are washout lenses : Standard single-vision spectacle lenses prescribed according to each participant's refractive error and worn during the washout period before allocation to the study lenses.
Receives: Device: Eye exam; Other: Questionnaires; Device: Washout lenses; Device: Reference lenses; Device: Test lenses
1st worn pair of glasses : Test / 2nd worn pair of glasses : ReferenceExperimentalThe very first pair of lenses worn before the experimental arm are washout lenses : Standard single-vision spectacle lenses prescribed according to each participant's refractive error and worn during the washout period before allocation to the study lenses.
Receives: Device: Eye exam; Other: Questionnaires; Device: Washout lenses; Device: Reference lenses; Device: Test lenses

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accommodative facility difference

    Measurement of the accommodative facility to understand the flexibility of the accommodation. It will be measured in cycle per minute (cpm) using a +/-2.00D flipper lens test at 40cm according to standard clinical accommodative facility testing procedures. Lenses are placed in front of the eyes to stimulated or not the accommodation on a text. The main goal of the participant is to keep clear and single the target while switching between the accommodative lenses and the non accommodative lenses.

    The results obtained after the wearing period of each lenses will be compared together.

    Measured: From enrollement to the end of the participation at about 16 weeks

Secondary outcomes (18)
  1. Visual fatigue questionnaire score

    Visual fatigue assessed using a validated questionnaire, CISS (Borsting et al, Optometry and Vision Science. 2003, 80(12):832-838). Total questionnaire scores (range 0 to 56 with a higher score meaning a higher fatigue) obtained after each lens-wear period will be compared between the reference lens and the test lens

    Measured: From enrollement to the end of the participation at about 16 weeks

  2. Visual Comfort Questionnaire Score

    Visual comfort assessed using a questionnaire administered at the end of each lens-wear period. Questionnaire scores (range from 0 to 182) will be compared between the reference lens and the test lens.

    Measured: From enrollement to the end of the participation at about 16 weeks

  3. Vision Quality Questionnaire Score

    Subjective quality of vision assessed using a questionnaire. Total questionnaire scores (range from 0 t o182) will be compared between the reference lens and the test lens.

    Measured: From enrollement to the end of the participation at about 16 weeks

  4. Participant Lens Preference

    Participant preference for the reference lens or the test lens assessed at the completion of both lens-wear periods using a preference questionnaire.

    Measured: From enrollement to the end of the participation at about 16 weeks

  5. Near Phoria

    Near phoria (in prismatic diopter) measured using standard clinical procedures. Phoria values obtained after participants wore the reference lens and the test lens will be compared.

    Measured: From enrollement to the end of the participation at about 16 weeks

  6. Sheard Criterion

    Sheard criterion calculated from measurements of phoria and fusional vergence reserves. Values obtained after participants wore the reference lens and the test lens will be compared.

    Measured: From enrollement to the end of the participation at about 16 weeks

  7. Vergence Capacity

    Vergence capacity assessed using fusional vergence measurements (in prismatic diopter) obtained under standard clinical conditions. Results after participants wore the reference lens and the test lens will be compared.

    Measured: From enrollement to the end of the participation at about 16 weeks

  8. Maximum Comfortable Convex And Concave Lens Power

    Maximum convex or concave lens power (in diopter) that can be comfortably accepted while maintaining clear binocular vision. Values obtained after participants wore the reference lens and the small-power lens will be compared.

    Measured: From enrollement to the end of the participation at about 16 weeks

  9. Accommodative Lag

    Accommodative lag measured in diopters during a near-vision task using an objective method of accommodation assessment. Values obtained after participants wore the reference lens and the test lens will be compared.

    Measured: From enrollement to the end of the participation at about 16 weeks

  10. Day effect on Accommodative Lag

    Difference in diopter between morning and evening accommodative lag measurements.

    Measured: From enrollement to the end of the participation at about 16 weeks

  11. Diurnal change in refraction

    Difference between morning and evening refraction measurements. Diurnal changes will be compared between the reference lens and the small-power lens conditions.

    Measured: From enrollement to the end of the participation at about 16 weeks

  12. Day effect on near phoria

    Difference between morning and evening measurements of near phoria (in prismatic diopter). Diurnal changes will be compared between the reference lens and the small-power lens conditions.

    Measured: From enrollement to the end of the participation at about 16 weeks

  13. Day effect on Sheard Criterion

    Difference between morning and evening Sheard criterion values. Diurnal changes will be compared between the reference lens and the small-power lens conditions.

    Measured: From enrollement to the end of the participation at about 16 weeks

  14. Day effect on AC/A ratio

    Difference between morning and evening accommodative convergence to accommodation (AC/A) ratio measurements. Diurnal changes will be compared between the reference lens and the small-power lens conditions.

    Measured: From enrollement to the end of the participation at about 16 weeks

  15. Diurnal change in Fusional Vergence Reserves

    Difference in prismatic diopter between morning and evening fusional vergence reserve measurements. Diurnal changes will be compared between the reference lens and the small-power lens conditions.

    Measured: From enrollement to the end of the participation at about 16 weeks

  16. Diurnal Change in Binocular Accommodative Facility

    Difference between morning and evening binocular accommodative facility measurements expressed in cycles per minute. Diurnal changes will be compared between the reference lens and the small-power lens conditions.

    Measured: From enrollement to the end of the participation at about 16 weeks

  17. Diurnal Change in Monocular Accommodative Facility

    Difference between morning and evening monocular accommodative facility measurements expressed in cycles per minute. Diurnal changes will be compared between the reference lens and the small-power lens conditions.

    Measured: From enrollement to the end of the participation at about 16 weeks

  18. Association Between Lens Satisfaction and Refractive Measures

    Association between participant satisfaction scores, cycloplegic refraction measurements, and subjective refraction measurements evaluated at the end of the study.

    Measured: From enrollment to the end of the participation at about 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionAug 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07859917
Sponsor's protocol ID
WS10412
Acronym
BIPBIP
Status last verified
Jun 2026
First submitted
30 Sep 2026
Last updated
6 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Eye exam, Questionnaires and Washout lenses in people with Healthy Young Adults and Accommodation Disorder, run by Essilor International at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Miriam Conway, PhD (+44 20 7040 8392, miriam.conway.1@city.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accommodative facility difference (time frame: From enrollement to the end of the participation at about 16 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in